rYojbaba Co Ltd Dossier
|
SectorIndustrials IndustryResearch and Consulting Services Beta (adjusted)1.00 Intrinsic Value $3.26median of 3 methodsbased on filings through 31 Dec 2025 Market Price $3.02Price as of 30 Sep 2026 Near fair valueIntrinsic value is 8% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $34.9M Enterprise Value $32.5M Shares Outstanding 10.5M diluted Moat Rating None Next Earnings Date13 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary rYojbaba Co., Ltd. (NASDAQ: RYOJ) presents a unique dual-business model combining labor consulting and osteopathic health services in Japan. While the company has successfully transitioned to profitability and secured a major JPY 500 million ($3.2 million) international labor support agreement with the International Labor Union (ILU), it remains a highly volatile micro-cap stock with concentrated voting control under CEO Ryoji Baba (approx. 69.5%). The health services segment provides stable cash flows with high repeat customer rates (>80% for osteopathic clinics), but long-term upside depends heavily on the scalability of its consulting services and the newly launched AI-powered Worker Risk Intelligence Platform. Given the high valuation multiples (TTM P/E around 295x) and limited public float, a Hold recommendation is advised until consistent execution of international labor agreements is demonstrated. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario Execution delays or regulatory hurdles in cross-border labor programs stall consulting revenue growth. High operational costs associated with clinic expansions and IT platform development depress margins, while concentrated voting control limits institutional investor interest, causing the stock to test historical lows. Base CaseCentral scenario The company successfully executes its JPY 500 million ILU agreement and expands its Free Labor Union Program with international partners. Osteopathic clinics maintain stable operations, and the AI-powered Worker Risk Intelligence Platform begins generating high-margin SaaS-like consulting revenues, leading to moderate valuation multiple compression and steady growth. Bull CaseUpside scenario Successful global commercialization of the AI-powered Worker Risk Intelligence Platform, driving high-margin SaaS revenue from institutional clients and expanding the clinic network internationally. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |